Protocol for the Isolation and Analysis of Extracellular Vesicles From Peripheral Blood: Red Cell, Endothelial, and Platelet-Derived Extracellular Vesicles

Background

This protocol outlines detailed steps for isolating extracellular vesicles (EVs) from human peripheral blood and characterizing them using flow cytometry [1]. It was developed as part of a study investigating EV release in patients with snakebite-associated thrombotic microangiopathy.

EVs play important roles in health and disease, but their small size, heterogeneity, and variable autofluorescence make analysis challenging [2]. Several techniques have been developed for EV analysis, including electron microscopy, nanoparticle tracking analysis, tunable resistive pulse sensing, western blotting, and ELISA-based assays, each with advantages and limitations [1]. Existing EV isolation protocols, including ultracentrifugation, precipitation, and size-exclusion chromatography, often face challenges such as incomplete removal of contaminating platelets, co-isolation of protein aggregates, variable EV recovery, and loss of vesicles during multiple washing steps [3]. Moreover, differences in centrifugation speeds, buffer preparation, and gating strategies limit reproducibility across laboratories [4]. Flow cytometry–based detection adds further complexity due to EV heterogeneity, variable autofluorescence, and the difficulty of distinguishing true EVs from debris [5].

Bead-based analysis of EVs is commonly used to overcome the challenge of their small size, which limits direct detection by conventional flow cytometry. In this approach, EVs are captured onto larger beads (typically 4–6 μm) coated with antibodies against tetraspanins such as CD63, CD81, or CD9, thereby increasing their effective size and enabling detection and characterization by flow cytometry. Once bound, the bead–EV complexes can be further probed with fluorescent antibodies to analyze additional surface markers and identify subpopulations. While this method is practical and widely accessible, it has important limitations: it selectively enriches only those EVs expressing the capture antigen (e.g., CD63⁺ vesicles if anti-CD63 beads are used), potentially overlooking other populations, and multiple EVs may attach to a single bead, preventing true single-vesicle resolution. Consequently, bead-based analysis provides useful phenotyping information but does not fully represent the heterogeneity of circulating EVs [6,8].

Our protocol addresses these issues by providing a standardized platelet-free plasma preparation method to minimize platelet contamination, with no unnecessary washing steps to reduce EV loss, use of filtered buffers to decrease background noise, and detailed stepwise explanations with troubleshooting guidance to improve reproducibility. Importantly, the protocol is a bead-free, flexible approach that can be adapted for different antibody panels and EV subtypes, enhancing its applicability compared with many existing protocols.